Treatment of Asymptomatic Toxocariasis With Albendazole in Children
Status:
Unknown status
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate effectiveness of albendazole in the treatment of the
asymptomatic infection with the parasite Toxocara in children. Treatment response is defined
as a reduction in the number of eosinophils in blood. The study drug will be compared to
placebo and randomly assigned in a double blind manner. Follow up will be prospective. 50
children (25 per group) will be enrolled in the study.